The Microcephaly Gene Panel Test is a specialized genetic test designed to identify mutations in genes associated with microcephaly, a condition characterized by a smaller head size than that typical for an infant's age and sex. This condition can result from a variety of genetic factors and can lead to developmental delays and neurological problems. Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to pinpoint specific genetic mutations linked to microcephaly. The comprehensive nature of this panel test makes it a crucial tool for diagnosing the condition accurately, thereby facilitating appropriate medical and developmental interventions. The cost of the Microcephaly Gene Panel Test at DNA Labs UAE is 7200 AED, reflecting the intricate technology and expertise required to perform this advanced genetic analysis.
The Muscular Dystrophy Gene Panel Test is a comprehensive genetic analysis designed to identify mutations across various genes associated with muscular dystrophy, a group of genetic disorders characterized by progressive muscle weakness and degeneration. This test is crucial for diagnosing specific types of muscular dystrophy, enabling healthcare providers to tailor treatment and management plans to the individual needs of their patients. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a thorough examination of the genetic markers linked to muscular dystrophy. The cost of the test is 7200 AED, reflecting the advanced technology and expertise required to perform this detailed genetic analysis. By opting for this test, individuals and families affected by muscular dystrophy can gain valuable insights into their condition, facilitating informed decisions about care and potentially accessing targeted therapies.
The Nervous System Cancer Gene Panel Test is a sophisticated diagnostic tool designed to identify genetic mutations associated with cancers of the nervous system. Conducted at DNA Labs UAE, this test screens for a comprehensive range of genetic markers that are known to influence the risk, development, and progression of nervous system cancers, including brain tumors. By analyzing a patient's DNA sample, usually obtained through a simple blood draw or biopsy, the test aims to provide critical insights into the genetic underpinnings of an individual's cancer, guiding personalized treatment strategies and management plans.
The cost of the Nervous System Cancer Gene Panel Test at DNA Labs UAE is 7200 AED. This investment covers the extensive analysis required to detect and interpret the specific genetic alterations that could impact a patient's cancer treatment and prognosis. The results from this test can help healthcare providers make informed decisions about targeted therapies, surveillance strategies, and potential participation in clinical trials, ultimately aiming to improve patient outcomes in the challenging landscape of nervous system cancers.
The Neuronal Ceroid Lipofuscinosis (NCL) Gene Panel Test is a comprehensive genetic test designed to identify mutations in genes associated with Neuronal Ceroid Lipofuscinosis, a group of progressive neurodegenerative disorders primarily affecting children. These disorders are characterized by the accumulation of lipofuscin, a fatty substance, in the body's tissues, leading to symptoms such as vision loss, motor decline, and seizures. The test analyzes multiple genes known to be linked to various forms of NCL, providing crucial information for accurate diagnosis and guiding treatment options.
Offered at DNA Labs UAE, this advanced genetic test is priced at 7200 AED. The facility utilizes cutting-edge technology and adheres to strict quality standards to ensure the reliability and accuracy of the test results. By opting for the NCL Gene Panel Test at DNA Labs UAE, patients and their families can gain valuable insights into the specific genetic mutations causing the disorder, facilitating early intervention and personalized care plans to manage the condition more effectively.
The Polycystic Kidney Disease Gene Panel Test is a sophisticated genetic screening designed to identify mutations in the genes associated with Polycystic Kidney Disease (PKD), a genetic disorder characterized by the growth of numerous cysts in the kidneys. This condition can lead to various health issues, including high blood pressure, kidney failure, and cysts in other organs. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the genes known to be linked to both the Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Autosomal Recessive Polycystic Kidney Disease (ARPKD), the two main types of PKD.
The test, priced at 7200 AED, involves collecting a DNA sample, typically through a blood draw, and examining it for specific genetic mutations. This detailed analysis helps in confirming a diagnosis of PKD, understanding the risk of developing the disease, and aiding in the decision-making process for family planning. Given the hereditary nature of PKD, the test is particularly recommended for individuals with a family history of the disease or those exhibiting symptoms related to PKD. Conducting the test at DNA Labs UAE ensures accuracy and reliability, backed by a team of genetic experts and state-of-the-art technology.
The Retinal Degeneration Gene Panel Test is a sophisticated diagnostic tool designed to identify genetic mutations associated with various forms of retinal degeneration, including age-related macular degeneration, retinitis pigmentosa, and Leber congenital amaurosis among others. By analyzing a comprehensive panel of genes known to be linked with these conditions, the test provides valuable insights that can aid in early diagnosis, management, and treatment planning for affected individuals.
Conducted at DNA Labs UAE, a leading facility renowned for its advanced genetic testing capabilities, the test harnesses cutting-edge sequencing technologies to accurately detect mutations that could lead to retinal degeneration. This is particularly crucial for individuals with a family history of retinal diseases, as it can offer predictive information and help in understanding the risk of developing such conditions.
The cost of the Retinal Degeneration Gene Panel Test at DNA Labs UAE is set at 7200 AED. While the price may seem significant, the comprehensive nature of the test, combined with the expertise and technological infrastructure of DNA Labs UAE, ensures a high level of accuracy and reliability in the results. For patients and families dealing with the challenges of retinal degeneration, this test represents a valuable investment in their health and well-being, providing essential information that can guide treatment decisions and potentially improve quality of life.
The Glucose-6-Phosphate Dehydrogenase (G6PD) Full-Length Gene Sequence Analysis Test is a comprehensive diagnostic procedure aimed at identifying mutations within the G6PD gene. This gene plays a crucial role in the normal processing of carbohydrates and is essential for the proper functioning of red blood cells. Mutations in the G6PD gene can lead to G6PD deficiency, a genetic disorder that can cause hemolytic anemia, jaundice, and other health issues upon exposure to certain medications, foods, or infections.
Performed at DNA Labs UAE, this test involves analyzing the entire length of the G6PD gene to detect any genetic variations that might lead to the disorder. This detailed analysis is crucial for accurate diagnosis, allowing for personalized treatment plans and management strategies for affected individuals. The test cost is 9010 AED, reflecting the intricate process and the sophisticated technology employed to ensure precise results. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic factors contributing to G6PD deficiency, facilitating informed decision-making and optimal care.
The Oncomine Myeloid Panel MDSMPNAMLCMLCMMLJMML Test, available at DNA Labs UAE, is a comprehensive genetic test designed to aid in the diagnosis and management of various myeloid disorders. This test focuses on a range of myeloid conditions, including Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML), and Juvenile Myelomonocytic Leukemia (JMML). By analyzing specific genetic mutations and alterations associated with these conditions, the panel provides valuable insights that can guide treatment decisions and prognosis assessments.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test employs cutting-edge sequencing technologies to ensure high accuracy and reliability of results. The cost of the Oncomine Myeloid Panel MDSMPNAMLCMLCMMLJMML Test is 7500 AED, reflecting the comprehensive nature of the analysis and the advanced technology used.
This test represents a crucial tool in the personalized medicine approach for myeloid disorders, offering patients and healthcare providers a detailed genetic profile that can influence treatment strategies and ultimately improve patient outcomes.
The "Pre-Implantation Genetic Disorder (PGD) Single Embryo with Maternal DNA Contamination Check Test" is a sophisticated diagnostic procedure offered by DNA Labs UAE, designed to screen embryos for genetic disorders before implantation. This test is particularly crucial for couples undergoing in vitro fertilization (IVF) who want to ensure their future child is free from specific genetic conditions. The inclusion of a maternal DNA contamination check is a critical component, as it ensures the accuracy of the test by distinguishing between the DNA of the embryo and potential contaminants from the mother's genetic material. This step is essential for providing clear and uncontaminated genetic results of the embryo itself.
The cost of this comprehensive test is set at 7500 AED. This investment covers the meticulous process of extracting a single cell from an embryo, analyzing its genetic makeup, and checking for any maternal DNA contamination to ensure the reliability of the test results. By opting for this test, prospective parents can make informed decisions about embryo implantation, significantly increasing their chances of a healthy pregnancy and reducing the risk of passing on hereditary genetic disorders. DNA Labs UAE, by offering this advanced genetic screening test, plays a pivotal role in the realm of reproductive health and genetic diagnostics, providing families with hope and options for a healthy future.
The "Solid Tumor Combo1 EGFRALK1ROS1METPDL1 Test" is a comprehensive molecular diagnostic assay offered by DNA Labs UAE, designed to identify genetic mutations and alterations in solid tumors. This advanced test focuses on a panel of genes including EGFR, ALK, ROS1, MET, and PD-L1, which are critical for the diagnosis, prognosis, and treatment planning for various cancers. By detecting mutations in these genes, the test can guide oncologists in choosing targeted therapies, thus personalizing the treatment approach for patients with solid tumors.
The cost of the Solid Tumor Combo1 Test is set at 7500 AED, reflecting the intricate technology and expertise involved in conducting this sophisticated analysis. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a significant advancement in cancer care, offering hope for more effective and tailored treatments for patients facing solid tumors.
